Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
8.04
-0.21 (-2.55%)
Dec 3, 2024, 1:48 PM EST - Market open
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $521.13 million as of December 3, 2024. Its market cap has increased by 669.76% in one year.
Market Cap
521.13M
Enterprise Value
488.83M
1-Year Change
669.76%
Ranking
Category
Stock Price
$8.11
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $521.13M, an increase of 79.20%. That is a compound annual growth rate of 6.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 530.10M | 514.25% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mind Medicine (MindMed) | 599.12M |
| CorMedix | 598.28M |
| IGM Biosciences | 597.02M |
| GRAIL | 588.01M |
| Astria Therapeutics | 586.35M |
| ProKidney | 583.32M |
| Humacyte | 581.58M |
| Olema Pharmaceuticals | 579.45M |